POLYMORPHISM OF ANGIOTENSIN-CONVERTING ENZYME (rs4340) AND DIABETIC NEPHROPATHY IN CAUCASIANS WITH TYPE 2 DIABETES MELLITUS
Šeruga M, Makuc J,, Završnik M, Cilenšek I, Ekart R, Petrovič D M. Šeruga and J. Makuc contributed equally to this study.
*Corresponding Author: Professor Dr. Daniel Petrovič, M.D., Ph.D., Institute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia. Tel: +386-1-543-7360. Fax: +386-1-543-7361. E-mail: daniel.petrovic@mf.uni-lj.si
page: 29

REFERENCES

1. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999; 341(15): 1127-1133. 2. Conway BR, Maxwell AP. Genetics of diabetic nephropathy: Are there clues to the understanding of common kidney diseases? Nephron Clin Pract 2009; 112(4): 213-221. 3. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care. 2005; 28(1): 164-176. 4. Carpena MP, Rados DV, Sortica DA, deSouza BM, Reis AF, Canani LH, et al. Genetics of diabetic nephropathy. Arq Bras Endocrinol Metab. 2010; 54(3): 254-261. 5. Kato M, Natarajan R. Diabetic nephropathy-emerging epigenetic mechanisms. Nat Rev Nephrol. 2014; 10(9): 517-530. 6. Bouchard J, Macedo E, Soroko S, Chertow GM, Himmelfarb J, Ikizler TA, et al. Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. Nephrol Dial Transplant. 2010; 25(1): 102-107. 7. Evans TC, Capell P. Diabetic nephropathy. Clin Diabetes. 2000; 18(1). (http://journal.diabetes.org/clinical diabetes/v18n12000/Pg7.htm.7) 8. Appel GB, Radhakrishnan J, Avram MM, DeFronzo RA, Escobar-Jimenez F, Campos MM, et al.; RENAL Study. Analysis of metabolic parameters as predictors of risk in the renal study. Diabetes Care. 2003; 26(5): 1402-1407. 9. Yacoub R, Campbell KN. Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis. 2015; 8(1): 29-40. 10. Gnudi L, Goldsmith D. Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes. F1000 Med Rep. 2010; 2. pii: 18. doi: 10.3410/M2-18. 11. Movva S, Alluri RV, Komandur S, Vattam K, Eppa K, Mukkavali KK, et al. Relationship of angiotensin- converting enzyme gene plymorphism with nephropathy associated with type 2 diabetes mellitus in Asian Indians. J Diabetes Complications. 2007; 21(4): 237-241. 12. Moon JY. Recent update of renin-angiotensin-aldosterone system in the pathogenesis of hypertension. Electrolyte Blood Press. 2013; 11(2): 41-45. 13. Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJ, et al. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: A systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011; 12(4): 624-633. 14. Glenn KL, Du ZQ, Eisenmann JC, Rothschild MF. An alternative method for genotyping of the ACE I/D polymorphism. Mol Biol Rep. 2009; 36(6): 1305-1310. 15. Zhou TB, Yin SS, Qin YH. Association between angiotensin- converting enzyme insertion/deletion gene polymorphism and end-stage renal disease susceptibility. J Renin Angiotensin Aldosterone Syst. 2014; 15(1): 22-31. 16. World Health Organisation, Part 1: Diagnosis and Clasification of Diabetes Mellitus: Report of a WHO consultation, In: Alwan A, King H. Definition, diagnosis and classification of diabetes mellitus and its complications. World Health Department of Noncommunicable Disease Surveillance, Geneva, Switzerland, 1999. 17. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene. Nucleic Acids Res. 1992; 20(6): 1433. 18. Shlipak M. Diabetic nephropathy. Clinical Evidence (Online), 2009,0606. Pii: 0606. Review. PubMed PMID: 19445773. PubMed Central PMCID: PMC290779. 19. Kumar R, Sharma RK, Agarwal S. Genetic predisposition for development of nephropathy in type 2 diabetes mellitus. Biochem Genet. 2013; 51(11-12): 865-875. 20. Gohda T, Makita Y, Shike T, Kobayashi M, Funabiki K, Haneda M, et al. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy. Clin Nephrol. 2001; 56(6): 475-480. 21. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C-based formulas for prediction of glomerular filtration rate in patients with chronic kidney disese. Nephron Clin Pract. 2010; 114(2): c118-c126. 22. Bevc S, Hojs R, Ekart R, Gorenjak M, Puklvec L. Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly. Ther Apher Dial. 2011; 15(3): 261-268. 23. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, et al. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP. 2001; 2(2): 83-87. 24. Wang Y, Ng MC, So WY, Tong PC, Ma RC, Chow CC, et al. Prognostic effect of insertion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. Diabetes Care. 2005; 28(2): 348-354. 25. Yu ZY, Chen LS, Zhang LC, Zhou TB. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy. Nephrology (Carlton). 2012; 17(5): 480-487. 26. Zhong W, Jiang Z, Zhou TB. Association between the ACE I/D gene polymorphism and T2DN susceptibility: The risk of T2DM developing into T2DN in the Asian population. J Renin Angiotensin Aldosterone Syst. 2015; 12(1): 1-9. 27. Al-Rubeaan K, Siddiqui K, Saeb AT, Nazir N, Al- Naqeb D, Al-Qasim S. ACE I/D and MTHFR C677T poly-morphisms are significantly associated with type 2 diabetes in Arab ethnicity: A meta-analysis. Gene. 2013; 520(2): 166-177. 28. Hadjadj S, Fumeron F, Roussel R, Saulnier PJ, Gallois Y, Ankotche A, et al.; DIABHYCAR Study Group; DIAB2NEPHROGENE Study Group; SURDIAGENE Study Group. Prognostic value of the insertion/ deletion polymorphism of the ACE gene in type 2 diabetic subjects: Results from the mon-insulindependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR), diabete de type 2, nephropathie et genetique (DIAB2NEPHROGENE), and survie, diabete de type 2 et genetique (SURDIAGENE) studies. Diabetes Care. 2008; 31(9): 1847-1852. 29. Hadjadj S, Tarnow L, Forsblom C, Kazeem G, Marre M, Groop PH, et al.; EURAGEDIC (European Rational Approach for Genetics of Diabetic Complications) Study Group. Association between angiotensinconverting enzyme gene polymorphisms and diabetic nephropathy: Case-control, haplotype, and familybased study in three European populations. J Am Soc Nephrol. 2007; 18(4): 1284-1291. 30. Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, Chatellier G, et al. Prognostic value of angiotensin- I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: A prospective study. J Am Soc Nephrol. 2001; 12(3): 541-549. 31. Nikzamir A, Rashidi A, Esteghamati A, Nakh-javani M, Golmohammadi T, Khalilzadeh O. The relationship between ACE gene insertion/deletion polymorphism and diabetic retinopathy in Iranian patients with type 2 diabetes. Ophthalmic Genet. 2010; 31(3): 108-113. 32. Jayapalan JJ, Muniandy S, Chan SP. Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects. Indian J Hum Genet. 2010; 16(2): 78-86. 33. Wang F, Fang Q, Yu N, Zhao D, Zhang Y, Wang J, et al. Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: A meta-analysis comprising 26,580 subjects. J Renin Angiotensin Aldosterone Syst. 2012; 13(1): 161-174. 34. Wang M, Zhang X, Song X, Zou X, Wu W, Wang Y, et al. Nodular glomerulosclerosis and renin angiotensin system in Chinese patients with type 2 diabetes. Mol Cell Endocrinol. 2016; 427(3):92-100.



Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006